Dermatomycoses of the glabrous skin : a double-blind, randomised, comparative trial of sertaconazole 2% cream once daily versus vehicle.

Author: , KortingHans C, StraussUwe Phillip, SusiloRudy

Paper Details 
Original Abstract of the Article :
OBJECTIVE: The aim of this multicentre, double-blind, vehicle-controlled study was to investigate the safety and efficacy of once-daily topical application of sertaconazole 2% cream compared with corresponding vehicle cream in the treatment of patients with tinea of glabrous skin. PATIENTS AND METH...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.2165/00044011-200323060-00002

データ提供:米国国立医学図書館(NLM)

Treating Skin Infections with Sertaconazole Cream: A Double-Blind Study

In the world of dermatology, tackling stubborn skin infections like tinea (a fungal infection) is a constant challenge. This study delves into the effectiveness of sertaconazole 2% cream, a topical treatment, in combating tinea of the glabrous skin (the smooth, hairless areas of the body). The researchers conducted a double-blind, vehicle-controlled study to assess the safety and efficacy of sertaconazole cream compared to a placebo cream. They enrolled 400 participants and followed them for 3 weeks, diligently tracking their progress.

Sertaconazole Cream Proves Its Worth: Cure Rates Exceed Expectations

The results are clear: sertaconazole 2% cream emerged as a winner. In both the intent-to-treat (ITT) and per-protocol (PP) populations, sertaconazole cream significantly outperformed the placebo. This success was evident in the high cure rates observed, particularly in those patients who initially had a positive mycological culture (indicating the presence of fungus). After 3 weeks of treatment, 82% of the PP population and 83% of the ITT population in the sertaconazole group showed negative culture results, compared to 61% and 59%, respectively, in the placebo group.

A Safe and Effective Treatment with Improved Patient Compliance

The study concluded that sertaconazole 2% cream is a safe and effective treatment option for superficial dermatomycoses. The once-daily application regimen stands out as a key advantage, potentially improving patient compliance – a crucial factor for successful treatment outcomes in dermatomycoses. This is especially important in the context of tinea, where consistent application is necessary to eliminate the fungus.

Dr. Camel's Conclusion

This research highlights the potential of sertaconazole cream as a valuable tool in the fight against skin infections. The researchers’ findings are promising, but further research is needed to explore the long-term effects and efficacy of this treatment in diverse populations. Think of it like this: Imagine a weary traveler in the desert, struggling with a stubborn fungal infection. Sertaconazole cream would be like a cool oasis, offering a safe and effective solution to soothe their troubled skin.
Date :
  1. Date Completed 2012-10-02
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

17535049

DOI: Digital Object Identifier

10.2165/00044011-200323060-00002

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.